DK1670785T3 - Salte og polymorphe former af en pyrrolsubstitueret indolinonforbindelse - Google Patents
Salte og polymorphe former af en pyrrolsubstitueret indolinonforbindelseInfo
- Publication number
- DK1670785T3 DK1670785T3 DK04769435.1T DK04769435T DK1670785T3 DK 1670785 T3 DK1670785 T3 DK 1670785T3 DK 04769435 T DK04769435 T DK 04769435T DK 1670785 T3 DK1670785 T3 DK 1670785T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyrrole
- salts
- polymorphic forms
- indolinone compound
- substituted indolinone
- Prior art date
Links
- -1 pyrrole-substituted indolinone compound Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50810403P | 2003-10-02 | 2003-10-02 | |
| PCT/IB2004/003070 WO2005033098A1 (en) | 2003-10-02 | 2004-09-20 | Salts and polymorphs of a pyrrole-substituted indolinone compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1670785T3 true DK1670785T3 (da) | 2010-10-18 |
Family
ID=34421700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04769435.1T DK1670785T3 (da) | 2003-10-02 | 2004-09-20 | Salte og polymorphe former af en pyrrolsubstitueret indolinonforbindelse |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7247627B2 (da) |
| EP (1) | EP1670785B1 (da) |
| JP (1) | JP4933259B2 (da) |
| KR (2) | KR20060058728A (da) |
| CN (1) | CN100432072C (da) |
| AR (1) | AR047762A1 (da) |
| AT (1) | ATE473223T1 (da) |
| AU (1) | AU2004277464B2 (da) |
| BR (1) | BRPI0415022A (da) |
| CA (1) | CA2540639C (da) |
| CY (1) | CY1110771T1 (da) |
| DE (1) | DE602004028028D1 (da) |
| DK (1) | DK1670785T3 (da) |
| ES (1) | ES2348623T3 (da) |
| IL (1) | IL174414A (da) |
| MX (1) | MXPA06003661A (da) |
| NO (1) | NO20061246L (da) |
| NZ (1) | NZ546001A (da) |
| PL (1) | PL1670785T3 (da) |
| PT (1) | PT1670785E (da) |
| RU (1) | RU2319702C2 (da) |
| SI (1) | SI1670785T1 (da) |
| TW (1) | TW200524921A (da) |
| WO (1) | WO2005033098A1 (da) |
| ZA (1) | ZA200602691B (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050182122A1 (en) * | 2003-11-20 | 2005-08-18 | Bello Carlo L. | Method of treating abnormal cell growth using indolinone compounds |
| US20090074787A1 (en) * | 2005-03-23 | 2009-03-19 | Pfizer, Inc., Pfizer Products, Inc. | Anti-CTLA4 Antibody and Indolinone Combination Therapy for Treatment of Cancer |
| KR20080040007A (ko) * | 2005-09-20 | 2008-05-07 | 화이자 프로덕츠 인크. | 티로신 키나제 억제제를 이용한 치료의 투여형 및 방법 |
| TWI384986B (zh) * | 2007-01-17 | 2013-02-11 | Lg Life Sciences Ltd | 抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物 |
| KR101428833B1 (ko) * | 2007-04-04 | 2014-08-08 | 오츠카 가가쿠 가부시키가이샤 | 티탄산칼륨, 그의 제조 방법, 마찰재 및 수지 조성물 |
| CN102159570B (zh) * | 2008-09-17 | 2014-01-15 | 诺瓦提斯公司 | N-[6-(顺式-2,6-二甲基吗啉-4-基)吡啶-3-基]-2-甲基-4’-(三氟甲氧基)[1,1’-联苯]-3-甲酰胺的盐 |
| RU2430361C1 (ru) * | 2010-07-05 | 2011-09-27 | Государственное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет им. В.Ф. Войно-Ясенецкого Министерства здравоохранения и социального развития Российской Федерации" | Способ прогнозирования риска развития диабетической ретинопатии при сахарном диабете типа 2 у якутов |
| WO2012042421A1 (en) | 2010-09-29 | 2012-04-05 | Pfizer Inc. | Method of treating abnormal cell growth |
| US9851313B2 (en) * | 2015-03-03 | 2017-12-26 | Panalytical B.V. | Quantitative X-ray analysis—ratio correction |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1575936A3 (ru) * | 1986-04-10 | 1990-06-30 | Е.И.Дюпон Де Немур Энд Ко.(Фирма) | Способ получени 3,3-дизамещенных индолин-2-ионов или их солей |
| US5534522A (en) * | 1995-06-07 | 1996-07-09 | Warner-Lambert Company | (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent |
| DE19622489A1 (de) * | 1996-06-05 | 1997-12-11 | Hoechst Ag | Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters |
| SK287142B6 (sk) * | 2000-02-15 | 2010-01-07 | Sugen, Inc. | Inhibítory proteínkináz na báze pyrolom substituovaného 2-indolinónu, farmaceutický prípravok s ich obsahom a ich použitie |
| AR042586A1 (es) * | 2001-02-15 | 2005-06-29 | Sugen Inc | 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa |
| JP4159988B2 (ja) | 2001-08-15 | 2008-10-01 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | Ｎ−［２−（ジエチルアミノ）エチル］−５−［（５−フルオロ−１，２−ジヒドロ−２−オキソ−３ｈ−インドール−３−イリデン）メチル］−２，４−ジメチル−１ｈ−ピロール−３−カルボキシアミドのリンゴ酸塩を含む結晶、その製法およびその組成物 |
| YU67702A (sh) | 2001-09-28 | 2004-12-31 | Pfizer Products Inc. | Postupak za dobijanje alkansulfonil piridina |
| TWI259081B (en) * | 2001-10-26 | 2006-08-01 | Sugen Inc | Treatment of acute myeloid leukemia with indolinone compounds |
| KR100657110B1 (ko) | 2002-02-15 | 2006-12-12 | 파마시아 앤드 업존 캄파니 엘엘씨 | 인돌리논 유도체의 제조방법 |
| TW200418836A (en) * | 2002-09-10 | 2004-10-01 | Pharmacia Italia Spa | Formulations comprising an indolinone compound |
-
2004
- 2004-09-20 DK DK04769435.1T patent/DK1670785T3/da active
- 2004-09-20 KR KR1020067006363A patent/KR20060058728A/ko not_active Ceased
- 2004-09-20 ES ES04769435T patent/ES2348623T3/es not_active Expired - Lifetime
- 2004-09-20 BR BRPI0415022-8A patent/BRPI0415022A/pt not_active IP Right Cessation
- 2004-09-20 WO PCT/IB2004/003070 patent/WO2005033098A1/en not_active Ceased
- 2004-09-20 PT PT04769435T patent/PT1670785E/pt unknown
- 2004-09-20 JP JP2006530728A patent/JP4933259B2/ja not_active Expired - Fee Related
- 2004-09-20 PL PL04769435T patent/PL1670785T3/pl unknown
- 2004-09-20 CA CA2540639A patent/CA2540639C/en not_active Expired - Fee Related
- 2004-09-20 EP EP04769435A patent/EP1670785B1/en not_active Expired - Lifetime
- 2004-09-20 CN CNB2004800287364A patent/CN100432072C/zh not_active Expired - Fee Related
- 2004-09-20 NZ NZ546001A patent/NZ546001A/en unknown
- 2004-09-20 AT AT04769435T patent/ATE473223T1/de active
- 2004-09-20 MX MXPA06003661A patent/MXPA06003661A/es active IP Right Grant
- 2004-09-20 SI SI200431486T patent/SI1670785T1/sl unknown
- 2004-09-20 KR KR1020087000428A patent/KR20080007520A/ko not_active Ceased
- 2004-09-20 AU AU2004277464A patent/AU2004277464B2/en not_active Ceased
- 2004-09-20 RU RU2006110541/04A patent/RU2319702C2/ru not_active IP Right Cessation
- 2004-09-20 DE DE602004028028T patent/DE602004028028D1/de not_active Expired - Lifetime
- 2004-09-30 US US10/956,420 patent/US7247627B2/en not_active Expired - Fee Related
- 2004-10-01 TW TW093129924A patent/TW200524921A/zh unknown
- 2004-10-01 AR ARP040103580A patent/AR047762A1/es not_active Application Discontinuation
-
2006
- 2006-03-17 NO NO20061246A patent/NO20061246L/no not_active Application Discontinuation
- 2006-03-20 IL IL174414A patent/IL174414A/en not_active IP Right Cessation
- 2006-03-31 ZA ZA200602691A patent/ZA200602691B/en unknown
-
2010
- 2010-09-03 CY CY20101100810T patent/CY1110771T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS8348A (is) | Samrunnin heteróhringasambönd | |
| DK1648889T3 (da) | Isethionatsalt af en selektiv CDK4-inhibitor | |
| IS8189A (is) | Ný útskipt 3-brennisteinsindól | |
| CY2015036I1 (el) | Νεα παραγωγα οξαζολιδινονης | |
| DK1912636T3 (da) | N-(arylamino)-sulfonamid-inhibitorer af mek | |
| DK1802579T3 (da) | Derivater af 3-arylaminopyridin | |
| IS8108A (is) | Ný efnasambönd | |
| DE602004017623D1 (de) | N-substituierte pyrazolyl-amidyl-benzimidazolyl-c-kit-inhibitoren | |
| DK1778672T3 (da) | Krystallinsk form af en biphenylforbindelse | |
| EP1689389A4 (en) | INDOLE COMPOUNDS | |
| ATE428701T1 (de) | Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2- | |
| DE602004032551D1 (de) | Hren dafür | |
| FI20021330A7 (fi) | Symbolijonon etsintä | |
| DK2371818T3 (da) | Hydroxybenzoatsalte af metanikotinforbindelser | |
| ATE430755T1 (de) | Wasserfreies kristallines azidocytosin-hemisulfat-derivat | |
| IS8228A (is) | Ný asetídínefnasambönd | |
| IS7585A (is) | Ný piperadín efnasambönd | |
| DK1670785T3 (da) | Salte og polymorphe former af en pyrrolsubstitueret indolinonforbindelse | |
| NO20070299L (no) | Novel heterocyclic compounds | |
| DK1575956T3 (da) | Fungicider på grundlag af nitrogenholdige heterocycliske forbindelser | |
| IS8292A (is) | Ný efnasambönd | |
| IS7833A (is) | Efnasambönd með sameinaða heteróhringi | |
| IS8109A (is) | Nýjar 3-dekladínósýl 9a-N-karbamóýl og 9a-N-þíókarbamóýl afleiður af 9-deoxó-9-díhýdró-9a-asa-9a-hómóerýþrómýsíni A | |
| NO20055097D0 (no) | Krystallinske N-formyl-hydroksylaminforbindelser | |
| DK1539768T3 (da) | Ny fremgangsmåde til fremstilling af epothilonderivater |